We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+17.9%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.6B
AUM Growth
+$1.99B
(+19%)
Cap. Flow
-$290M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
21.14%
Holding
876
New
80
Increased
408
Reduced
263
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$146M |
| 2 |
Salesforce
CRM
|
+$65.4M |
| 3 |
Merck
MRK
|
+$57.9M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$50.8M |
| 5 |
Citigroup
C
|
+$46.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$76.3M |
| 2 |
VSLR
VIVINT SOLAR, INC.
VSLR
|
+$35.6M |
| 3 |
ADSW
Advanced Disposal Services Inc
ADSW
|
+$31.7M |
| 4 |
BioNTech
BNTX
|
+$25.5M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.01% |
| 2 | Technology | 22.68% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 7.85% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Agios Pharmaceuticals
AGIO
$1.95B
| $10.5M | 0.08% |
241,987
-135,618
| -36% | -$5.36M |
|
|
EV
252
DELISTED
Eaton Vance Corp.
EV
| $10.2M | 0.08% |
+150,037
| New | +$9.37M |
|
|
IPHI
253
DELISTED
INPHI CORPORATION
IPHI
| $10.2M | 0.08% |
+63,252
| New | +$8.89M |
|
|
DCPH
254
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $10.1M | 0.08% |
176,636
-72,883
| -29% | -$4.32M |
|
|
RESI
255
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $10.1M | 0.08% |
+621,829
| New | +$8.63M |
|
256
Agilent Technologies
A
$39.2B
| $10M | 0.08% |
84,719
+19,062
| +29% | +$2.11M |
|
257
Williams Companies
WMB
$86.7B
| $9.97M | 0.08% |
423,768
+80,105
| +23% | +$1.62M |
|
258
Intellia Therapeutics
NTLA
$1.55B
| $9.95M | 0.08% |
+182,917
| New | +$6.64M |
|
259
Restaurant Brands International
QSR
$25.8B
| $9.89M | 0.08% |
161,949
+7,318
| +5% | +$427K |
|
|
BNY
260
Bank of New York Mellon
BNY
$106B
| $9.86M | 0.08% |
232,246
+21,839
| +10% | +$839K |
|
|
SWTX
261
DELISTED
SpringWorks Therapeutics
SWTX
| $9.86M | 0.08% |
+135,880
| New | +$8.75M |
|
262
Hartford Financial Services
HIG
$39.2B
| $9.78M | 0.08% |
199,656
+32,666
| +20% | +$1.41M |
|
263
Oneok
OKE
$56.1B
| $9.75M | 0.08% |
227,174
+71,880
| +46% | +$2.42M |
|
264
Atmos Energy
ATO
$29.1B
| $9.74M | 0.08% |
102,037
+66,384
| +186% | +$6.4M |
|
265
Baxter International
BAX
$13.8B
| $9.74M | 0.08% |
121,346
+71,787
| +145% | +$5.69M |
|
|
ALLK
266
DELISTED
Allakos
ALLK
| $9.65M | 0.08% |
68,951
-42,921
| -38% | -$4.47M |
|
267
Kinder Morgan
KMI
$70.5B
| $9.65M | 0.08% |
705,671
+163,502
| +30% | +$2.19M |
|
|
IGMS
268
DELISTED
IGM Biosciences
IGMS
| $9.61M | 0.08% |
108,892
-21,395
| -16% | -$1.5M |
|
269
Workday
WDAY
$39B
| $9.46M | 0.07% |
39,472
-6,821
| -15% | -$1.53M |
|
270
State Street
STT
$50.2B
| $9.45M | 0.07% |
129,832
+8,818
| +7% | +$599K |
|
271
Axsome Therapeutics
AXSM
$12.1B
| $9.44M | 0.07% |
115,802
+15,347
| +15% | +$1.15M |
|
272
Insmed
INSM
$22B
| $9.42M | 0.07% |
282,901
-9,099
| -3% | -$332K |
|
|
EIGI
273
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $9.33M | 0.07% |
+987,610
| New | +$8.17M |
|
274
Berkshire Hathaway Class B
BRK.B
$1.1T
| $9.2M | 0.07% |
39,765
-68,646
| -63% | -$15.1M |
|
|
KSU
275
DELISTED
Kansas City Southern
KSU
| $9.07M | 0.07% |
44,450
-2,828
| -6% | -$531K |
|
Similar funds
PCM
A
MGP
LF
BPA
MIM
SPIA
Candriam SCA's Q4 2020 Portfolio in Review
As of Q4 2020, Candriam SCA held 876 positions worth $12.6B, up 19% from $10.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA's Q4 2020 filing shows 80 new, 408 increased, 263 reduced and 68 closed positions. Its largest new stake was Salesforce: 269,070 shares worth $59.9M. The largest sale was Amazon, an estimated $76.3M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
- Candriam SCA's largest Q4 2020 buy was Salesforce: 269,070 shares worth $59.9M.
- Candriam SCA added most to Apple in Q4 2020, an estimated $146M increase.
- Candriam SCA's biggest Q4 2020 reduction was Amazon, cutting an estimated $76.3M.
- Candriam SCA fully exited VIVINT SOLAR, INC. in Q4 2020, selling an estimated $35.6M.
- Candriam SCA's ten largest holdings make up 21% of its $12.6B portfolio in Q4 2020.
- Candriam SCA opened 80 new positions and closed 68 in Q4 2020.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $12.6B.
Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.